24-Feb-2026
Everus Construction Posts Record 2025 Results, Strong Backlog
TipRanks (Tue, 24-Feb 5:26 PM ET)
Seeking Alpha News (Tue, 24-Feb 4:40 PM ET)
Everus Reports Fourth Quarter and Full-Year 2025 Results, Initiates Guidance for 2026
Business Wire (Tue, 24-Feb 4:30 PM ET)
Everus Construction Group to Hold Fourth Quarter and Full-Year 2025 Results Webcast Feb. 25
Business Wire (Wed, 28-Jan 4:30 PM ET)
Everus Construction Group Inc is a construction solutions provider, offering specialty contracting services to a diverse set of end markets across the U.S. It operates across two segments Electrical & Mechanical (E&M) and Transmission & Distribution (T&D), and delivers services through its subsidiaries. It generates the majority of revenue from the Electrical & Mechanical segment which offers a wide variety of specialty contracting services, including construction and maintenance of electrical and communication wiring, fire suppression systems, and mechanical piping and services, to customers in both the public and private sectors. Its T&D segment serves electric and natural gas utility customers, as well as customers in the transportation end market, in the West and Midwest regions.
Everus Construction Group trades on the NYSE stock market under the symbol ECG.
As of February 24, 2026, ECG stock price declined to $104.21 with 831,672 million shares trading.
ECG has a beta of 1.68, meaning it tends to be more sensitive to market movements. ECG has a correlation of 0.38 to the broad based SPY ETF.
ECG has a market cap of $5.31 billion. This is considered a Mid Cap stock.
Last quarter Everus Construction Group reported $987 million in Revenue and $1.11 earnings per share. This beat revenue expectation by $160 million and exceeded earnings estimates by $.49.
The top ETF exchange traded funds that ECG belongs to (by Net Assets): IJR, VTI, AIRR, VB, SPSM.
ECG has outperformed the market in the last year with a price return of +139.2% while the SPY ETF gained +15.8%. ECG has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +26.3% and +2.6%, respectively, while the SPY returned +4.6% and -1.0%, respectively.
ECG support price is $102.07 and resistance is $110.09 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ECG shares will trade within this expected range on the day.